Metraipolis › archive › dc_fed06a0410da
Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice — Europe PMC PMID:42133079
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42133079
- DOI
- 10.1007/s00520-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T06:40:59.074Z
- SHA-256 of the archived text
8eeb7ed716d7433daa10f4a2f352efaf87f5c61388f1739f7991ec9ad9de9f6d- Stable URL of this page
https://metraipolis.com/documento/dc_fed06a0410da
How to cite
Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice — Europe PMC PMID:42133079 — Europe PMC (en), https://europepmc.org/article/MED/42133079 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fed06a0410da (Metraipolis archive dc_fed06a0410da, sha256 8eeb7ed716d7433daa10f4a2f352efaf87f5c61388f1739f7991ec9ad9de9f6d)
BibTeX
@misc{dcfed06a0410da,
title = {Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice — Europe PMC PMID:42133079},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42133079},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fed06a0410da; sha256 8eeb7ed716d7433daa10f4a2f352efaf87f5c61388f1739f7991ec9ad9de9f6d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42133079. Agents can read the archived copy with the MCP tool read_document.